Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
BMC Gastroenterology|April 28, 2016
Evaluation of dose-efficacy of sorafenib and effect of transarterial chemoembolization in hepatocellular carcinoma patients: a retrospective studyWang-De Hsiao, Cheng-Yuan Peng, Po-Heng Chuang, et al.
Plos One|January 3, 2018
Changes in liver stiffness measurement using acoustic radiation force impulse elastography after antiviral therapy in patients with chronic hepatitis CSheng-Hung Chen, Hsueh-Chou Lai, I-Ping Chiang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 1, 2019
Performance of Acoustic Radiation Force Impulse Elastography for Staging Liver Fibrosis in Patients With Chronic Hepatitis C After Viral EradicationSheng-Hung Chen, Hsueh-Chou Lai, I-Ping Chiang, et al.
Cancers|May 13, 2020
On-Treatment Changes in FIB-4 and 1-Year FIB-4 Values Help Identify Patients with Chronic Hepatitis B Receiving Entecavir Therapy Who Have the Lowest Risk of Hepatocellular CarcinomaHung-Wei Wang, Hsueh-Chou Lai, Tsung-Hui Hu, et al.
Journal of Clinical Medicine|February 20, 2020
Sequential Circulating Tumor Cell Counts in Patients with Locally Advanced or Metastatic Hepatocellular Carcinoma: Monitoring the Treatment ResponseKun-Ming Rau, Chien-Ting Liu, Yu-Chiao Hsiao, et al.
American Journal of Cancer Research|January 8, 2021
Predictors of response and survival in patients with unresectable hepatocellular carcinoma treated with nivolumab: real-world experienceWei-Fan Hsu, Po-Heng Chuang, Cheng-Kuo Chen, et al.
BMC Complementary Medicine and Therapies|July 16, 2020
Decreased overall mortality rate with Chinese herbal medicine usage in patients with decompensated liver cirrhosis in TaiwanFuu-Jen Tsai, Pei-Yuu Yang, Chao-Jung Chen, et al.
Liver Cancer|July 21, 2025
Consensus Guideline of Ablation for Metastatic Liver Tumors by Taiwan Academy of Tumor AblationMing Shun Wu, Wei-Yu Kao, Ming-Feng Chiang, et al.
American Journal of Cancer Research|March 10, 2023
Combined CRAFITY score and α-fetoprotein response predicts treatment outcomes in patients with unresectable hepatocellular carcinoma receiving anti-programmed death-1 blockade-based immunotherapyWei-Fan Hsu, Hsueh-Chou Lai, Cheng-Kuo Chen, et al.
American Journal of Cancer Research|January 12, 2022
Alpha-fetoprotein response predicts treatment outcomes in patients with unresectable hepatocellular carcinoma receiving immune checkpoint inhibitors with or without tyrosine kinase inhibitors or locoregional therapiesWei-Fan Hsu, Hung-Wei Wang, Cheng-Kuo Chen, et al.
Pageof 5